𝔖 Bobbio Scriptorium
✦   LIBER   ✦

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)

✍ Scribed by Souglakos, J; Androulakis, N; Syrigos, K; Polyzos, A; Ziras, N; Athanasiadis, A; Kakolyris, S; Tsousis, S; Kouroussis, Ch; Vamvakas, L

Book ID
109998747
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
128 KB
Volume
94
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

FOXFIRE protocol: an open-label, randomi
FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer
✍ Susan J Dutton,Nicola Kenealy,Sharon B Love,Harpreet S Wasan… πŸ“‚ Article πŸ“… 2014 πŸ› BioMed Central 🌐 English βš– 333 KB
Gemcitabine, epirubicin and paclitaxel (
Gemcitabine, epirubicin and paclitaxel (GET) vs. 5-fluorouracil, epirubicin and cyclophosphamide (FEC) as first-line treatment in metastatic breast cancer: interim toxicity analysis of a randomised, multicenter phase iii trial of the Central European Cooperative Oncology Group (CECOG)
✍ T. Brodowicz; S. Beslija; J. Cervek; Z. Mrsic-Krmpotic; I. Tchernozemsky; C. Wil πŸ“‚ Article πŸ“… 2001 πŸ› Elsevier Science 🌐 English βš– 166 KB